Warning! GuruFocus detected
2 Severe warning signs
with 25I.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
ImmuPharma PLC
NAICS : 325412
ISIN : GB0033711010
Description
ImmuPharma PLC is a drug discovery and development company. The pipeline of the company includes novel peptide-based therapeutics within two therapy areas: autoimmunity & inflammation, and anti-infectives. The company's drug candidate is Lupuzor, which treats lupus, a life-threatening autoimmune disease.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.66 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 35.8 | |||||
| 3-Year EPS without NRI Growth Rate | 37.7 | |||||
| 3-Year FCF Growth Rate | 39.4 | |||||
| 3-Year Book Growth Rate | -57.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.18 | |||||
| 9-Day RSI | 39.72 | |||||
| 14-Day RSI | 43.45 | |||||
| 3-1 Month Momentum % | 131.82 | |||||
| 6-1 Month Momentum % | 75.86 | |||||
| 12-1 Month Momentum % | 82.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | |||||
| Quick Ratio | 1.6 | |||||
| Cash Ratio | 0.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -18.5 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | 3612.86 | |||||
| Net Margin % | 3517.14 | |||||
| FCF Margin % | 2298.77 | |||||
| ROE % | -134.68 | |||||
| ROA % | -73.33 | |||||
| ROIC % | -117.16 | |||||
| 3-Year ROIIC % | -111.39 | |||||
| ROC (Joel Greenblatt) % | -1501.57 | |||||
| ROCE % | -157.14 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 5.48 | |||||
| Price-to-Tangible-Book | 2.05 | |||||
| EV-to-EBIT | -4.69 | |||||
| EV-to-EBITDA | -4.72 | |||||
| EV-to-Revenue | -192.44 | |||||
| EV-to-FCF | -8.48 | |||||
| Price-to-GF-Value | 0.41 | |||||
| Earnings Yield (Greenblatt) % | -21.32 | |||||
| FCF Yield % | -11.61 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ImmuPharma PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | -0.081 | ||
| EPS (TTM) (€) | -0.008 | ||
| Beta | -13.79 | ||
| 3-Year Sharpe Ratio | 0.82 | ||
| 3-Year Sortino Ratio | 25.98 | ||
| Volatility % | 2508.55 | ||
| 14-Day RSI | 43.45 | ||
| 14-Day ATR (€) | 0.008407 | ||
| 20-Day SMA (€) | 0.0324 | ||
| 12-1 Month Momentum % | 82.14 | ||
| 52-Week Range (€) | 0.0005 - 0.093 | ||
| Shares Outstanding (Mil) | 416.44 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ImmuPharma PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ImmuPharma PLC Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
ImmuPharma PLC Frequently Asked Questions
What is ImmuPharma PLC(FRA:25I)'s stock price today?
The current price of FRA:25I is €0.02. The 52 week high of FRA:25I is €0.09 and 52 week low is €0.00.
When is next earnings date of ImmuPharma PLC(FRA:25I)?
The next earnings date of ImmuPharma PLC(FRA:25I) is 2025-06-05 Est..
Does ImmuPharma PLC(FRA:25I) pay dividends? If so, how much?
ImmuPharma PLC(FRA:25I) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers